Revolution Medicines (RVMD) Other Accumulated Expenses (2019 - 2026)
Revolution Medicines (RVMD) reported Other Accumulated Expenses of $5.15 million for Q2 2026, compared with $462,000 a year earlier and up 57.8% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Revolution Medicines posted Other Accumulated Expenses of $7.86 million.
- Other Accumulated Expenses has a five-year compound annual growth rate of 140.8% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $583,000 in FY2024 (-85.0%), $3.9 million in FY2023 (+671.5%), $505,000 in FY2022 (+62.4%) and $311,000 in FY2021 (+220.6%).
- Five-year quarterly Other Accumulated Expenses spans a low of $125,000 in Q3 2021 and a high of $8.24 million in Q3 2025.
- Year over year, Other Accumulated Expenses gained in three of the last six quarters, with growth averaging 164.1%.
- The high point for year-over-year Other Accumulated Expenses in five years was Q4 2023 (growth of 671.5%); the low point was Q4 2024 (a decline of 85.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.26 million (Q1 2026), $7.86 million (Q4 2025) and $8.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.15 Mn |
| Mar 31, 2026 | 3.26 Mn |
| Dec 31, 2025 | 7.86 Mn |
| Sep 30, 2025 | 8.24 Mn |
| Jun 30, 2025 | 462,000.00 |
| Mar 31, 2025 | 651,000.00 |
| Dec 31, 2024 | 583,000.00 |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 657,000.00 |
| Mar 31, 2024 | 744,000.00 |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 480,000.00 |
| Jun 30, 2023 | 350,000.00 |
| Mar 31, 2023 | 397,000.00 |
| Dec 31, 2022 | 505,000.00 |
| Sep 30, 2022 | 488,000.00 |
| Jun 30, 2022 | 647,000.00 |
| Mar 31, 2022 | 280,000.00 |
| Dec 31, 2021 | 311,000.00 |
| Sep 30, 2021 | 125,000.00 |
API Access
Revolution Medicines Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();